Autopsy report · NCT01043601
Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control
Cause of deathOther
“Similar data obtained in another study \[see NCT01085045\], therefore study not implemented.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Pearl Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- COPD
- Interventions
- Inhaled PT005; Inhaled Placebo; Formoterol Fumarate 12 µg (Foradil Aerolizer)
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Vaping High vs. Low Nicotine E-Liquid
“Please see NCT04053868 for the current version of this study” - Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
“This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07007702.” - Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
“No results are avaialble as the study did not complete according to the protocol” - The Effect of Movement Education on Jumping/Landing Quality in High School Athletes
“Study was updated and is now under IRB #2023-0499” - The Role of GLP-1 in Satiety Perception in Humans
“This study is delayed. It was not funded.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.